CRISPR Therapeutics

CRSP • NASDAQ • Stock Fundamentals

CRISPR Therapeutics is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Samarth Kulkarni, with a market cap of $4.9B.

Market Cap$4.9B

Employees407.0

CEOSamarth Kulkarni

CountrySwitzerland

Healthcare

Biotechnology

Most Recent EarningsMay 4, 2026 · 22 days agoQ1 2026

Next EarningsAug 3, 2026 · in 2 monthsQ2 2026

Financials

Based on Q1 2026 filing

Common questions about CRISPR Therapeutics

CRISPR Therapeutics (CRSP) has a market capitalization of $4.9B and trades on NASDAQ.

CRISPR Therapeutics has approximately 407 employees.